Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.

Zhou SL, Yue WB, Fan ZM, Du F, Liu BC, Li B, Han XN, Ku JW, Zhao XK, Zhang P, Cui J, Zhou FY, Zhang LQ, Fan XP, Zhou YF, Zhu LL, Liu HY, Wang LD.

Dis Esophagus. 2014 Nov-Dec;27(8):790-7. doi: 10.1111/dote.12145. Epub 2013 Oct 21.

PMID:
24147952
2.

Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.

Zhou SL, Ku JW, Fan ZM, Yue WB, Du F, Zhou YF, Liu YL, Li Y, Tang S, Hu YL, Hu XP, Hou ZC, Liu J, Liu Y, Feng XS, Wang LD.

Dis Esophagus. 2015 May-Jun;28(4):371-9. doi: 10.1111/dote.12206. Epub 2014 Mar 10.

PMID:
24612004
3.

Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.

Liu W, Wang P, Li Z, Xu W, Dai L, Wang K, Zhang J.

Scand J Immunol. 2009 Jan;69(1):57-63. doi: 10.1111/j.1365-3083.2008.02195.x.

4.

Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.

Qin JJ, Wang XR, Wang P, Ren PF, Shi JX, Zhang HF, Xia JF, Wang KJ, Song CH, Dai LP, Zhang JY.

Asian Pac J Cancer Prev. 2014;15(6):2635-40.

5.

Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.

Li P, Shi JX, Xing MT, Dai LP, Li JT, Zhang JY.

Tumour Biol. 2017 Oct;39(10):1010428317711662. doi: 10.1177/1010428317711662.

PMID:
29022480
6.

Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.

Liu W, De La Torre IG, GutiƩrrez-Rivera MC, Wang B, Liu Y, Dai L, Qian W, Zhang JY.

Tumour Biol. 2015 Feb;36(2):1307-12. doi: 10.1007/s13277-014-2756-5. Epub 2014 Oct 30.

PMID:
25355596
7.

Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.

Li J, Wang LJ, Ying X, Han SX, Bai E, Zhang Y, Zhu Q.

Scand J Immunol. 2012 Mar;75(3):342-9. doi: 10.1111/j.1365-3083.2011.02657.x.

8.

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.

Dong J, Zeng BH, Xu LH, Wang JY, Li MZ, Zeng MS, Liu WL.

J Transl Med. 2010 Sep 3;8:81. doi: 10.1186/1479-5876-8-81.

9.

Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.

Wang P, Song C, Xie W, Ye H, Wang K, Dai L, Zhang Y, Zhang J.

J Immunol Res. 2014;2014:512540. doi: 10.1155/2014/512540. Epub 2014 Apr 13.

10.

Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.

Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK.

J Hepatol. 2007 Jan;46(1):107-14. Epub 2006 Sep 25.

11.

Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.

Zhou JH, Zhang B, Kernstine KH, Zhong L.

World J Gastroenterol. 2011 Mar 14;17(10):1373-8. doi: 10.3748/wjg.v17.i10.1373.

12.

[The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].

Kim SG, Hong SJ, Kwon KW, Jung SW, Kim WY, Jung IS, Ko BM, Ryu CB, Kim YS, Moon JH, Kim JO, Cho JY, Lee JS, Lee MS, Shim CS, Kim BS.

Korean J Gastroenterol. 2006 Oct;48(4):269-76. Korean.

13.

Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.

Gao H, Zheng Z, Mao Y, Wang W, Qiao Y, Zhou L, Liu F, He H, Zhao X.

Cancer Lett. 2014 Mar 1;344(1):54-61. doi: 10.1016/j.canlet.2013.10.007. Epub 2013 Oct 22.

PMID:
24157810
14.

A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer.

Zhang HF, Qin JJ, Ren PF, Shi JX, Xia JF, Ye H, Wang P, Song CH, Wang KJ, Zhang JY.

Cancer Immunol Immunother. 2016 Oct;65(10):1233-42. doi: 10.1007/s00262-016-1886-6. Epub 2016 Aug 23.

PMID:
27553002
15.

Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.

Dai L, Li J, Ortega R, Qian W, Casiano CA, Zhang JY.

J Immunol Res. 2014;2014:827827. doi: 10.1155/2014/827827. Epub 2014 Apr 17.

16.

Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.

Chai Y, Peng B, Dai L, Qian W, Zhang Y, Zhang JY.

Scand J Immunol. 2014 Nov;80(5):362-8. doi: 10.1111/sji.12202.

17.

Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.

Xu YW, Peng YH, Chen B, Wu ZY, Wu JY, Shen JH, Zheng CP, Wang SH, Guo HP, Li EM, Xu LY.

Am J Gastroenterol. 2014 Jan;109(1):36-45. doi: 10.1038/ajg.2013.384. Epub 2013 Dec 3.

18.

Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.

Jin Y, Guan S, Liu L, Sun S, Lee KH, Wei J.

Asia Pac J Clin Oncol. 2015 Dec;11(4):e37-41. doi: 10.1111/ajco.12198. Epub 2014 May 9.

PMID:
24811068
19.

Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.

Looi K, Megliorino R, Shi FD, Peng XX, Chen Y, Zhang JY.

Oncol Rep. 2006 Nov;16(5):1105-10.

PMID:
17016600
20.

Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):136-43.

Supplemental Content

Support Center